Cantourage Group Cantourage has continued its run of positive financial results, reporting record profits for the third quarter and
Voyager Life Voyager Life, which recently rebranded as Mendell Helium, has announced the sale of its cannabis-facing business after
LONG-ESTABLISHED European cannabis company Bedrocan has re-entered the Canadian medical cannabis market following the purchase of a facility in Toronto.
Argent BioPharma Argent BioPharma (formerly MGC Pharmaceuticals) has released its latest preliminary financial figures for the year to June
Celadon Pharmaceuticals Celadon Pharmaceuticals this week released its full-year results for 2023, reporting revenues over three times those seen
Germany’s passage of CanG continues to drive up stock prices Yesterday, the President of Bundesrat, Manuela Schwesig, signed Germany’s landmark
Ananda Developments Ananda Developments has seen its stock increase over 5% this week after signing a ‘Drug Supply Agreement’ (DSA)
Akanda Akanda has seen its share price slip by around 10% this week after it announced plans to sell
Cantourage Cantourage Group reported its Q3 financial figures this week, celebrating ‘significant revenue growth’ so far in 2023, but
Cantourage Group SE (hereinafter “Cantourage,” ISIN: DE000A3DSV01, www.cantourage.com), a leading European company for the production and distribution of medical cannabis,
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
